Janice Bourque Email & Phone Number

Boston, Ma, Us

Boston, Ma; Jbourque@Htgc.Com

Hercules is the leading specialty finance company providing venture debt and equity to venture capital and private equity-backed technology and life science companies at all stages of developmentSince 2005 Hercules has committed over $8.5 billion in commitments to over 450 companies with $1.94B assets under management. With 150 IPOs and M&A exits and over 1000 co-investments with VC and PE firms Hercules Capital have provided shareholders with 54 consecutive quarters of distributions since 2005. We primarily focus on venture-backed private companies at all stages of development, and small-mid cap public companies. Our investment range is typically between $5 and $75 million per company. We are a publicly traded fund (NYSE: HTGC) backed by well-known funds and have maintained strong access to capital throughout our history. Some of the uses of our capital by our portfolio companies have been to: a) extend cash runway and reach new value inflection points, b) in-license new technology, c) acquisitions, d) shore-up the balance sheet ahead of negotiations with strategic partners or ahead/after a potential IPO, e) push the development of a new or secondary program or technology, and f) provide low dilution capital alongside public investors.

Boston Ma

Commons Capital is an early stage venture capital fund that invests in "double bottom-line" innovative early-stage companies whose technology, products, services, or corporate culture exhibit strong financial returns as well as significant social and environmental impact.Provide the strategic corporate investor fundraising and advise the general partners for a Gates supported Commons Capital and Oxford Bioscience Partners joint venture $100MM fund focused on innovative healthcare investments for developing and emerging countries.

Boston Ma

Comerica is a financial services company headquartered in Texas representing $63.6B in assets. Comerica’s Technology & Life Sciences Division is focused on emerging technology and life science companies throughout their life cycle with strong relationships with top-tier investors. Led the Life Sciences Commercial Debt Group with responsibility for turning around an under-performing team. The group was losing market share as a result of unprecedented market competition among regulated and non-regulated debt providers; an extremely tight credit underwriting environment, and inexperience with a non-traditional customer profile. •Leveraged industry contacts to restore and rebuild the customer base, increased business flow by 50 opportunities per year generating referral transactions by cross selling trust, foreign exchange, cash management and other bank products services.•Raised brand recognition by closing highly visible deals which were previously unachievable. This improved the perception of the bank and resulted in higher profitability through deposits and debt size.•Created Venture Capital Advisory board with managing directors from top 12 Life Sciences Venture Funds.•Mentored and rebuilt team into a collaborative and responsive team.•Educated both senior management and credit committee on non-traditional customer risks and risk management.•Financed significant deals through creative venture debt financing as follows:- Originated $600K in largest office fee through a successful $5M lawsuit debt financing.- Closed on $5-7M debt bridge financing (per deal) for top 3 M&A deals in biotech industry.- Generated $1.3M in warrant income due to customer acquisitions & deal structure-Co-financed $10-20M debt facility (per deal) for 2 major leading biotech firms.•Generated 4 years of profitability averaging 1M in annual profit

Cambirdge Ma

Launched and grew the MBC to an organization that provided an arena for collaboration among industry leaders while raising awareness of biotechnology locally and globally. Management and Financial Success• Stimulated capital formation by creating the first regional biotechnology investor conference MassOpportunities.• Quadrupled a diverse membership from 80 companies to 425. * Provided budget revenue growth from $500K to over $4MM with profitability for 10 consecutive years.• Achieved highest program profitability and contract payment for BIO2000 Convention by attracting a record 15,000 delegates to Boston.• Created a motivated, knowledgeable and dedicated staff within a creative culture.• Created MassBioEd, the first biotechnology educational foundation that provided college scholarships, high school equipment and training; specialized workforce training programs and advocacy for strong high school and middle school math/science curriculums • Developed the first model comprehensive web based MA Biotechnology Industry and Career Directory. Industry Growth, Public Awareness and Public Policy• Launched the 1st Biotechnology Association in the world.• Led creation of the industry blueprint report MassBiotech2010. • Created MA as a focal point of international biotechnology leadership.• Created two nationally first biotechnology newspaper publications in the Boston Globe.• Influence the creation of the Boston Globe “Innovation” section by engaging media during BIO2000 resulting in 5 continuous days of front page coverage of biotechnology.• Established strong, respected political relationships with national, state and local leaders and regulatory agencies. • Established first Bioethics Advisory Group with national thought leaders from Harvard, Boston University and industry. • Supported the creation of the first State pharmacy benefit insurance program Prescription Advantage for the elderly and disabled.

Billerica Ma

Boston Ma

Emerging and middle-market group with clients Genetics Institute and Serono Laboratories

Durham Nh

Executive Development Program Certificate, Leadership And Influence

Bs, Veterinary Science

Mba, Finance And Accounting